Cdx2, one of the mouse homologs of Drosophila melanogaster caudal 1 , is a key transcription factor for intestinal development and differentiation [2] [3] [4] . Cdx2 +/-mice develop one or two hamartomas in the proximal colon 5, 6 , and several lines of evidence suggest that reduced expression of CDX2 may be responsible for colon carcinogenesis [7] [8] [9] [10] . To examine this possibility, we introduced a Cdx2 mutation into Apc ∆716 knockout mice that serve as a model for human familial adenomatous polyposis 11, 12 . Although Apc ∆716 and other Apc mutant mice form polyps mostly in the small intestine, the Apc +/∆716 Cdx2 +/-compound mutant mice developed polyps mainly in the colon, where most human polyps are formed, due to a higher frequency of LOH at Apc associated with chromosomal instability.
A R T I C L E S

Interdependent regulation between Apc and Cdx2
To determine the relationship between Cdx2 suppression and colonic polyposis, we estimated Cdx2 mRNA levels in the colonic mucosa and polyps. Because we had inserted a β-galactosidase gene (lacZ) into the Cdx2 knockout allele, we monitored Cdx2 promoter activity by lacZ expression 6 . In both Cdx2 +/-and Apc +/∆716 Cdx2 +/-mice, we observed little X-gal staining in the distal colon, where more than 90% of the polyps formed (Fig. 2a) . Consistent with low Cdx2 expression (Fig. 1a) , X-gal staining was weak in the polyps in Apc +/∆716 Cdx2 +/-mice, regardless of their sizes (Fig. 2a-c) . These results indicate that expression of Cdx2 is suppressed at an early stage of colonic polyposis.
We further quantified CDX2 protein in subregions of the normal (polyp-free) colon by western-blot analysis. In wild-type mice, we found a low but significant concentration of CDX2 in the distal colon (Fig. 2d) . CDX2 concentration was lower in Apc ∆716 and Cdx2 +/-heterozygotes, at 52% and 30% of wild-type concentration, respectively (Fig. 2e) . Notably, CDX2 concentration was even lower in Apc +/∆716 Cdx2 +/-mice (16% of wild-type concentration). Because expression of APC protein is also stimulated by CDX2 in colon cancer cells 4 , we then quantified colonic APC (Fig. 2f) . Compared with the wild-type distal colon, APC concentration was lower in Apc ∆716 and Cdx2 +/-mice (64% and 62% of wild-type concentration, respectively) and still lower in Apc +/∆716 Cdx2 +/-mice (only 12% of wild-type concentration). These data indicate that heterozygosity with respect to Cdx2 reduces expression of Apc as well as Cdx2 itself to very low levels in the distal colon through their interdependent regulation. Although the precise molecular mechanism for this has not yet been determined, our preliminary results rule out DNA methylation in the Cdx2 promoter (data not shown). Anaphase bridge formation in Apc +/∆716 Cdx2 +/-colon Because Apc +/∆716 Cdx2 +/-mice had more colonic polyps but no alteration in polyp size distribution, polyp initiation rather than polyp expansion seemed to be stimulated. As polyps are initiated by LOH at Apc in Apc ∆716 mice 11 , we determined the Apc genotype in the Apc +/∆716 Cdx2 +/-polyp adenomas. In all examined, the PCR band for the wild-type Apc allele was lost, whereas that for the wild-type Cdx2 allele was retained in the same polyps (Fig. 3a) .
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LOH in Apc Min mice is caused by homologous recombination near the centromere 13, 14 . Consistent with this, a mutation in DNA helicase or telomerase in Apc Min mice increases the number of intestinal polyps because of high frequency of recombination and chromosomal instability 15, 16 . In the anaphase of cell cycle, such chromosomal instability can be assessed by the frequency of 'anaphase bridges' , extended chromosome bridging between two spindle poles 15, 17 . We first scored anaphase bridge index (ABI) in the normal colonic epithelium. We found very few anaphase bridges in wild-type and Apc ∆716 mice (ABI mean ± s.d. = 0.3 ± 0.6%; Fig. 3b,c) . In contrast, the ABI in Cdx2 +/-mice was four times higher (1.3 ± 0.5%) and in Apc +/∆716 Cdx2 +/-mice was ten times higher (3.4 ± 0.6%; Fig. 3b,c) . In the colonic polyps, the ABI was ∼2.5 times higher in both Cdx2 +/-hamartomas (6.3 ± 2.1%) and Apc +/∆716 Cdx2 +/-adenomas (6.3 ± 1.9%) than in Apc ∆716 adenomas (2.5 ± 1.8%; Fig. 3b,c) . Because the ABIs were higher in Cdx2 +/-mice in both normal colonic and hamartoma epithelia, it seemed that the Cdx2 mutation itself was sufficient to increase ABI. Lack of APC also enhanced chromosomal instability 18, 19 , as the ABI was higher in the Apc ∆716 polyps than in the normal epithelium (Fig. 3b) .
Increased ABI by suppression of CDX2 in cultured cells
To investigate chromosomal instability further, we reduced endogenous CDX2 levels to ∼10% in normal rat intestinal epithelial cells (IEC-6) and human colon cancer cells (DLD-1) by expressing an antisense RNA (Fig. 4a,b) . The ABI was about ten times higher in the low CDX2 clones (15-34%) than in control clones (2.0-4.5%; Fig. 4c,d) . These results show that low CDX2 levels induce anaphase bridges also in cultured cells, and that the effect on chromosomal instability is independent of APC, because DLD-1 cells lack wild-type APC 20 whereas IEC-6 cells retain it.
NATURE GENETICS
To assess the effects of higher ABI on chromosome number in low CDX2 DLD-1 clones, we first determined their DNA contents by flow cytometry. The proportion for the 2N-4N DNA-containing cells was similar between low CDX2 clones and controls (Fig. 4e) , ruling out massive changes in DNA contents, such as polyploidization. We then determined the karyotypes of low CDX2 DLD-1 clones after ∼40 doublings. Although only 11% of control DLD-1 cells contained new chromosomal losses or gains, 42% of the metaphase low CDX2 cells did ( Fig. 4f and Supplementary Table 1 online) . These results present convincing evidence that suppression of CDX2 causes chromosomal instability both in vivo and in cultured cells.
Suppression of CDX2 accelerates G 1 -S transition
To investigate the mechanisms by which low CDX2 levels caused high ABI, we first compared cell cycle distributions between low CDX2 and control DLD-1 clones. In the presence of 10% fetal bovine serum (FBS), the G 1 phase was shorter whereas S was longer in all low CDX2 clones (Fig. 5a) . In contrast, the mitotic spindle checkpoint in response to colcemid treatment remained unaffected in low CDX2 clones (Fig. 5b) . We also found accelerated G 1 progression on serum starvation of low CDX2 clones in both 1% (Fig. 5c ) and 0.1% FBS (data not shown). These results show that low CDX2 clones undergo accelerated G 1 -S transition even under serum starvation.
Activation of mTOR in low CDX2 DLD-1 cells
To investigate the molecular mechanisms behind the accelerated G 1 progression in low CDX2 clones, we quantified some cell cycle-related proteins and determined the kinase activities. Low CDX2 clones had less p27 and significantly greater cyclin E-associated kinase activity, with greater Cdk2 phosphorylation at Thr160 (Fig. 5d) . On the other hand, low CDX2 clones had normal amounts of p21, Cdk2 and cyclins D, E and A and no changes in cyclin A-dependent Cdk2 activity (Fig. 5d) .
Because activation of phosphoinositide-3-kinase (PI3K) or the Ras-Erk pathway accelerates G 1 progression 21 , we next examined some proteins in these pathways in low CDX2 DLD-1 clones. Notably, phosphorylation of p70S6 kinase1 (S6K1) was significantly greater at Thr389, the rapamycin-sensitive site 22 (Fig. 5e) . Phosphorylation of 4E-BP1 and the intensity of its γ-band were also greater (Fig. 5e) . In contrast, Akt, one of the downstream effectors from PI3K and an upstream effector of mTOR, was unaffected in low CDX2 clones. Phosphorylation of PDK1 was also unaffected. There were no significant changes in the concentrations or phosphorylation status of the proteins in the Ras-Erk pathway (Fig. 5e) . Because activation of Wnt signaling can cause G 1 progression 23, 24 , we also determined the β-catenin-TCF transcription activity in the low CDX2 clones. We found no significant changes (data not shown). Thus, the mTOR pathway must be activated in low CDX2 clones.
Suppression of mTOR activity by expression of CDX2
To verify the suppressive role of CDX2 in mTOR signaling, we then expressed CDX2 in DLD-1 cells at high levels (Fig. 6a) . Phosphorylation of S6, one of the primary downstream targets of S6K1, was significantly lower in high CDX2 DLD-1 clones cultured in 0.1% FBS, although the effect was milder in those cultured in 10% FBS (Fig. 6a) . These results show a reciprocal relationship between the cells with low and high CDX2 levels with respect to mTOR signaling. We also examined other colon cancer cell lines RKO and HCT116 that expressed little endogenous CDX2. On forced expression of CDX2, phosphorylation of S6 was lower and G 1 -S transition was suppressed in both cell lines (data not shown).
mTOR signaling and cell survival in Cdx2 +/-mutant colon To confirm the roles of CDX2 in vivo, we first quantified G 1 cyclins in mouse colonic mucosa. The amount of cyclin E was greater in both normal and polyp epithelia in distal colons of Apc +/∆716 Cdx2 +/-mice than in those of Apc ∆716 mice (Fig. 6b) . High cyclin E level is presumed to cause G 1 -S progression and chromosomal instability in mice as reported in cultured fibroblasts and epithelial cells 25, 26 . The level of phosphorylated S6 was also higher in colonic mucosa of Apc +/∆716 Cdx2 +/-mice (Fig. 6b) . These data confirm that mTOR signaling is stimulated in the colonic epithelium with low CDX2.
To examine the effects of low CDX2 on cell survival, we next determined indices for bromodeoxyuridine (BrdU) labeling and apoptosis in Cdx2 +/-and Apc +/∆716 Cdx2 +/-mice. The mean BrdU labeling index in the distal colon of Cdx2 +/-mice was 1.7 times higher than in wild-type mice (Fig. 6c,d) . We obtained essentially the same results in Apc +/∆716 Cdx2 +/-mice (data not shown). Spontaneous apoptotic rates in the crypt proliferative zone 27 were significantly lower in Cdx2 +/-and Apc +/∆716 Cdx2 +/-mice than in wild-type and Apc ∆716 mice, respectively (Fig. 6e,f) . This suppression of apoptosis was much more prominent in distal than proximal colon. These results suggest that the Cdx2 mutation has direct effects on cell survival rather than acting indirectly through the Apc mutation. In contrast, we found markedly different results in the small intestine. The BrdU labeling index was 40% lower and the apoptotic index was ∼3 times higher in both Cdx2 +/-and Apc +/∆716 Cdx2 +/-mice than in wild-type and Apc ∆716 mice, respectively (Supplementary Fig. 2  online) . These results indicate that the roles of CDX2 in cell survival regulation are markedly different between the small intestine and colon, which may explain the opposite polyposis phenotypes (Supplementary Fig. 2 online) .
mTOR inhibitors suppress anaphase bridge formation
Because premature entry into S phase was reported to cause genomic instability even in the absence of extrinsic DNA damage 28 , we hypothesized that activation of the mTOR pathway stimulated anaphase bridge formation by accelerating the G 1 -S transition in Apc +/∆716 Cdx2 +/-mice and low CDX2 cells. Accordingly, we treated low CDX2 DLD-1 clones with LY294002, an inhibitor of PI3K and mTOR, and with rapamycin, an mTOR inhibitor 29 . Inhibition of mTOR was confirmed by reduced phosphorylation of downstream effectors S6K1 and 4E-BP1 (Supplementary Fig. 3 online) . As anticipated, both LY294002 and rapamycin reduced ABI in a dose-dependent manner (Fig. 7a) , and the greater activities of Cdk2 and cyclin E-Cdk2 in low CDX2 DLD-1 cells were attenuated by LY294002. The level of p27 was increased by LY294002 in low CDX2 cells as in control DLD-1 cells, although to a lesser extent. On the other hand, the levels of Akt and of Akt phosphorylated at Thr308 were unaffected by the inhibitor. The level of p21 was not affected by the inhibitor either ( Supplementary Fig. 3 online) . An MEK1/2 inhibitor PD98059 did not affect ABI (Fig. 7a) or the level of p27. These results confirm that activation of mTOR pathway causes anaphase bridge formation.
To determine whether the decrease in ABI by LY294002 was caused during the G 1 -S transition, we analyzed which cell cycle phase was susceptible to the inhibitor. We treated low CDX2 DLD1 clones with the inhibitor either in G 1 -early S phase or in mid S-G 2 /M phase (Fig. 7b) . Notably, the compound suppressed ABI only when the cells were exposed during G 1 -early S phase (Fig. 7b) .
These results suggest that LY294002 reduces ABI by its effect on the G 1 -S transition, and that reduced CDX2 levels cause anaphase bridges through activation of the mTOR pathway during G 1 -early S.
Expression of activated Akt increases ABI
Finally, we expressed constitutively active Akt in DLD-1 cells, activating mTOR 30 . Activation of Akt and mTOR were confirmed by phosphorylation of GSK3-α/β and greater phosphorylation of S6K1 and S6, respectively (Supplementary Fig. 3 online) . As expected, we found much higher ABI in all constitutively active Akt clones (Fig. 7c) .
To verify the role of mTOR signaling in anaphase bridge formation, we then treated constitutively active Akt DLD-1 clones with LY294002 and rapamycin. The inhibition of mTOR signaling was confirmed by western-blot analysis of the downstream molecules ( Supplementary  Fig. 3 online) . As anticipated, both compounds significantly reduced ABI (Fig. 7d) . Thus, these results confirm that greater mTOR activity is responsible for higher ABI in Apc +/∆716 Cdx2 +/-colon and low CDX2 clones. Because the levels of CDX2 in constitutively active Akt DLD-1 clones was unaffected ( Supplementary Fig. 3 online), we conclude that CDX2 is an upstream regulator of mTOR.
DISCUSSION
In Apc ∆716 and other Apc mutant mice, most polyps are formed in the small intestine rather than in the colon. This is one of the biggest differences between these mouse models and human familial adenomatous polyposis. Here, we showed that Apc +/∆716 Cdx2 +/-mice develop polyps primarily in the colon (Fig. 1) , a phenotype more similar to human polyposis.
The enhanced colonic polyposis may occur by several mechanisms that can increase the frequency of polyp initiation. First, chromosomal instability seems to increase the frequencies of LOH at Apc in the colonic epithelium (Figs. 3 and 4) because of recombination near the centromere 13, 14 . Second, the higher proliferation rate should expand the proliferating cell population (Fig. 6c,d) . And third, the lower apoptotic rate may allow more cells with LOH at Apc to survive and form polyps (Fig. 6e,f) . Cells with high ABI often undergo apoptosis at higher rates 15, 31 . On the other hand, we see no significant increase in the apoptotic index in either Cdx2 heterozygous colon or low CDX2 DLD1 cells (data not shown). Accordingly, apoptosis reported in other mutants is probably the result of chromosomal instability rather than its cause, and such apoptosis is probably suppressed significantly in cells with low CDX2.
On the other hand, the decreased polyp number in the small intestine in Apc +/∆716 Cdx2 +/-mice can be explained by reduced cell survival in the crypt and adenoma epithelia. Expression of cyclin D and c-Myc was reduced in the small intestinal polyps in Apc +/∆716 Cdx2 +/-mice ( Supplementary Fig. 2 online) . The level of phosphorylated MEK1/2 was also reduced. These results suggest that in the small intestine, Cdx2 mutation causes downregulation of Ras-Erk signaling, followed by reduction in cell survival that results in suppression of polyposis in Apc ∆716 mice.
The present results suggest a mechanism that causes chromosomal instability by low CDX2 levels (Fig. 7e) . Our interpretation is consistent with earlier reports that chromosomal instability can be caused by defects in early cell cycle events, even without extrinsic DNA damage 26, 28, 32 .
In human colon carcinogenesis, genetic instability is found at early stages 33, 34 , and chromosomal instability precedes APC mutations 35 . In later stages, chromosomal aberrations and LOH are more frequently observed [36] [37] [38] and ABI is increased 15 . Expression of CDX2 is reduced in most colorectal cancer 8 and even more reduced in malignant progression 7 . Based on the present findings, it is possible that reduced expression of CDX2, and resulting chromosomal instability, affect human colorectal carcinogenesis at various stages.
Although we did not find any signs of malignant progression in the Apc +/∆716 Cdx2 +/-mice before they died at ∼30 weeks of age, they probably could not survive long enough to develop such changes. Alternatively, chromosomal instability may affect tumorigenesis differently in mice than in humans, owing to the speciesspecific chromosomal organization of genes. It is conceivable that the frequencies of recombination and LOH at the specific heterozygous tumor suppressor gene loci are different depending on their relative positions to the recombination hotspots targeted by chromosomal instability 39 . The increase in chromosomal instability probably affects Apc as well as other tumor suppressor genes, enhancing both tumor initiation and progression.
CDX2 is involved in the development, differentiation and physiology of the intestines. Disruption of TOR causes intestinal atrophy in Caenorhabditis elegans 40 In conclusion, we show that reduced Cdx2 expression has key roles in causing chromosomal instability, cell proliferation and suppression of apoptosis in colonic epithelial cells. The chromosomal instability in the low CDX2 cells is caused by activation of the mTOR pathway. These results may help make it possible to prevent and treat chromosomal instability cancers with rapamycin derivatives or other inhibitors of mTOR pathway.
METHODS
Mice and polyp scoring. Apc ∆716 and Cdx2 +/-knockout mouse strains were described previously 6, 11 . They were derived from 129/Sv embryonic stem cells and backcrossed to the C57BL/6 strain. We used Cdx2 +/-in N [5] [6] [7] and Apc ∆716 in N 18 . We scored polyps in the intestines as described 11 . All animal experiments were approved by the Animal Care and Use Committee of Kyoto University.
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VOLUME Pathology, histopathology and histochemical and immunohistochemical analyses. We carried out pathologic examinations of necropsied mice and histopathologic analyses as described 12, 43 . We used histochemical and immunohistochemical procedures described previously 6, 43 . We obtained rabbit antibody for a human/mouse β-catenin peptide from Sigma.
Determination of ABI.
We analyzed anaphase cells as described previously 15 , except those specimens were stained with DAPI and observed under a fluorescent microscope. We scored cells with tripolar or more spindles also. For colonic crypts and colonic polyps, we scored ∼600 and ∼300 anaphase cells, respectively. We purchased kinase inhibitors LY294002, rapamycin and PD98059 from Calbiochem. For cultured cells, we scored more than 100 anaphase cells for each sample. We calculated each ABI from at least three experiments.
Northern-and western-blot analyses and kinase assays. We extracted total RNA using Isogen (Nippon Gene) and purified poly(A) + RNA using OligotexdT30 (TaKaRa). We prepared hybridization probes for Cdx2 and Gapd as described previously 6 . We carried out hybridization using ExpressHyb (Clontech). For western blots, we separated cell lysates 43 (50 µg protein) by PAGE and analyzed blotted membranes using rabbit antibodies from Santa Cruz Biotechnology (for human cyclins A, D, and E, c-Myc, p21, S6K1 and Cdk2). Rabbit polyclonal antibody for the C terminus of human APC, crossreacting with mouse APC, was also from Santa Cruz. Antibody for p27 was from BD PharMingen; those for Akt, phosphorylated Akt (at Thr308 and Ser473), MEK1/2, phosphorylated MEK1/2 (Ser217/221), phosphorylated Cdk2 (Thr160), phosphorylated PDK1 (Ser241), phosphorylated GSK3α/β (Ser21/9), S6, phosphorylated S6 (Ser235/236 and Ser240/244), 4E-BP1, phosphorylated 4E-BP1 (Ser65) and phosphorylated S6K1 (Thr389) were from Cell Signaling Technology. We prepared the antibody to mouse CDX2 as described 44 ; antibody for β-actin was from Sigma. We analyzed kinase activities as described 45 .
LOH analysis and plasmids. We carried out tissue LOH analysis for Apc as described 12 . For LOH at Cdx2, we used the following primers: wild-type Cdx2 allele, LOHCdx2F2 and LOHCdx2WTR4. For the knockout Cdx2 allele, we used PGKR and LOHCdx2WTRR5. The sequences of the primers are available from authors. We constructed the antisense CDX2 plasmid pCMV-α-hCDX2 (Fig. 4a) using pCMV-Tag1 vector (Stratagene). The 562-bp antisense cDNA fragment of human CDX2 had 61 bases different from the corresponding rat sequence (89% identity). We obtained mouse Cdx2 cDNA in pCB6 vector 4 from J.-N. Freund (Institut National de la Santé et de le Recherche Médicale, Strasbourg). We purchased the expression vector for constitutively active Akt (myr-Akt) from Upstate Biotechnology.
Cells and transfection.
We obtained human colon cancer cell line DLD-1 (ref. 46) and rat intestinal epithelial cell line IEC-6 (ref. 47 ) from M. Tsujii (Osaka University) and purchased RKO and HCT116 from American Type Culture Collection. We cultured cells in Dulbecco's modified Eagle's medium supplemented with 10% FBS (GIBCO). We transfected plasmids using Lipofectamine Plus (Invitrogen).
Cell cycle and karyotype analyses. We inoculated cells at 1 × 10 6 per 85-mm dish the day before analysis. When applicable, we labeled cells with 10 µM BrdU for 1 h before fixing them with cold 70% ethanol (for ∼1 h). We collected cells, treated them with 4N HCl in phosphate-buffered saline for 30 min and stained them for BrdU with mouse monoclonal antibody to BrdU conjugated to fluorescein isothiocyanate (BD Pharmingen). We carried out flow cytometry for 1 × 10 5 cells in a FACScan (B & D) using CellQuest software package. To study the mitotic spindle checkpoint, we treated cultured cells with 1 µg ml -1 colcemid (Sigma) for 3 h. All experiments were repeated at least twice. We carried out karyotype analysis by G-banding as described 46 and spectral karyotype analysis using SkyPaint probe mixture (Applied Spectral Imaging) according to the manufacturer's protocol.
BrdU and TUNEL staining and Wnt transcription activity. We carried out BrdU labeling for 4 h as described previously 12 . We determined apoptotic index as described 27 . Transfection assays with β-catenin-TCF reporter plasmids (Upstate Biotechnology) were done as described 48 .
Note: Supplementary information is available on the Nature Genetics website.
